Skip to content

LIFECORE BIOMEDICAL, INC.

LFCR

CIK 0001005286

← back to feed
Revenue (TTM)
$473.75M
−1.8% YoY Q1 Apr 2026
Net Income (TTM)
−$46.31M
−527.3% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$1.39
−500.0% YoY Q1 Apr 2026
Gross Margin
7.0%
Q1 Apr 2026
Operating Margin
-4.0%
Q1 Apr 2026
Net Margin
-9.8%
Q1 Apr 2026
Free Cash Flow (TTM)
−$4.69M
Q1 Apr 2026
Cash
$20.8M
Q1 Apr 2026
Total Debt
$111.49M
Q1 Apr 2026
Shares Outstanding
37.51M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings